Tempest Therapeutics, Inc. Earnings Per Share, Basic and Diluted
Tempest Therapeutics, Inc. (TPST) reported Earnings Per Share, Basic and Diluted of -$1.21 per share for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-11-10
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$1.21.
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$7.63.
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.44.
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$11.22.
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2020 was -$1.93.
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2019 was -$3.25.
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2018 was -$17.58.
- Tempest Therapeutics, Inc. earnings per share, basic and diluted for fiscal 2017 was -$321.81.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 3 month as first filed | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 6 month as first filed | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 9 month as first filed | Earnings Per Share, Basic and Diluted 12 month | Earnings Per Share, Basic and Diluted 12 month as first filed | Earnings Per Share, Basic and Diluted 15 month | Earnings Per Share, Basic and Diluted 18 month | Earnings Per Share, Basic and Diluted 21 month | Earnings Per Share, Basic and Diluted 24 month | Earnings Per Share, Basic and Diluted 27 month | Earnings Per Share, Basic and Diluted 30 month | Earnings Per Share, Basic and Diluted 33 month | Earnings Per Share, Basic and Diluted 36 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | -$1.21 10-Q · filed 2021-11-10 | -$7.49 10-Q · filed 2021-11-10 | ||||||||||||||
| 2021-06-30 | -$7.63 10-Q · filed 2021-08-12 | -$17.30 10-Q · filed 2021-08-12 | ||||||||||||||
| 2021-03-31 | -$0.44 10-Q · filed 2021-05-13 | |||||||||||||||
| 2020-12-31 | -$1.93 10-K · filed 2021-03-29 | |||||||||||||||
| 2020-09-30 | -$11.22 10-Q · filed 2021-11-10 | -$0.34 10-Q · filed 2020-11-09 | -$31.91 10-Q · filed 2021-11-10 | -$1.54 10-Q · filed 2020-11-09 | ||||||||||||
| 2020-06-30 | -$11.42 10-Q · filed 2021-08-12 | -$0.56 10-Q · filed 2020-08-10 | -$21.28 10-Q · filed 2021-08-12 | -$1.21 10-Q · filed 2020-08-10 | ||||||||||||
| 2020-03-31 | -$0.65 10-Q · filed 2021-05-13 | |||||||||||||||
| 2019-12-31 | -$3.25 10-K · filed 2021-03-29 | |||||||||||||||
| 2019-09-30 | -$0.87 10-Q · filed 2020-11-09 | -$2.38 10-Q · filed 2020-11-09 | ||||||||||||||
| 2019-06-30 | -$0.74 10-Q · filed 2020-08-10 | -$1.51 10-Q · filed 2020-08-10 | ||||||||||||||
| 2019-03-31 | -$0.78 10-Q · filed 2020-05-08 | |||||||||||||||
| 2018-12-31 | -$17.58 10-K · filed 2020-03-11 | |||||||||||||||
| 2018-09-30 | -$10.61 10-Q · filed 2019-11-13 | -$0.16 10-Q · filed 2018-11-09 | -$23.43 10-Q · filed 2019-11-13 | -$0.58 10-Q · filed 2018-11-09 | ||||||||||||
| 2018-06-30 | -$6.82 10-Q · filed 2019-08-12 | -$0.22 10-Q · filed 2018-08-09 | -$12.82 10-Q · filed 2019-08-12 | -$0.42 10-Q · filed 2018-08-09 | ||||||||||||
| 2018-03-31 | -$6.00 10-Q · filed 2019-05-15 | -$0.21 10-Q · filed 2018-05-03 | ||||||||||||||
| 2017-12-31 | -$321.81 10-K · filed 2019-04-01 | -$1.43 10-K · filed 2018-03-15 | ||||||||||||||
| 2017-09-30 | -$0.26 10-Q · filed 2018-11-09 | -$1.19 10-Q · filed 2018-11-09 | ||||||||||||||
| 2017-06-30 | -$0.51 10-Q · filed 2018-08-09 | -$0.93 10-Q · filed 2018-08-09 | ||||||||||||||
| 2017-03-31 | -$0.42 10-Q · filed 2018-05-03 | |||||||||||||||
| 2016-12-31 | -$2.56 10-K · filed 2018-03-15 | |||||||||||||||
| 2016-09-30 | -$0.54 10-Q · filed 2017-11-02 | -$1.92 10-Q · filed 2017-11-02 | ||||||||||||||
| 2016-06-30 | -$0.62 10-Q · filed 2017-08-03 | -$1.41 10-Q · filed 2017-08-03 | ||||||||||||||
| 2016-03-31 | -$0.80 10-Q · filed 2017-05-09 | |||||||||||||||
| 2015-12-31 | -$2.70 10-K · filed 2018-03-15 | |||||||||||||||
| 2015-09-30 | -$0.66 10-Q · filed 2016-11-03 | -$1.95 10-Q · filed 2016-11-03 | ||||||||||||||
| 2015-06-30 | -$0.64 10-Q · filed 2016-08-04 | -$1.29 10-Q · filed 2016-08-04 | ||||||||||||||
| 2015-03-31 | -$0.65 10-Q · filed 2016-05-05 | |||||||||||||||
| 2014-12-31 | -$2.19 10-K · filed 2017-03-02 | |||||||||||||||
| 2014-09-30 | -$0.54 10-Q · filed 2015-11-05 | -$1.38 10-Q · filed 2015-11-05 | ||||||||||||||
| 2014-06-30 | -$0.42 10-Q · filed 2015-08-10 | -$0.83 10-Q · filed 2015-08-10 | ||||||||||||||
| 2014-03-31 | -$0.41 10-Q · filed 2015-05-11 | -$1.03 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$1.44 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$1.80 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$5.73 10-Q · filed 2014-05-08 | |||||||||||
| 2013-12-31 | -$0.64 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$1.04 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$1.40 derived: net income ÷ weighted average shares · filed 2016-02-26 | -$1.80 10-K · filed 2016-02-26 | -$5.42 10-K · filed 2014-02-27 | |||||||||||
| 2013-09-30 | -$0.40 10-Q · filed 2014-11-10 | -$0.76 derived: net income ÷ weighted average shares · filed 2014-11-10 | -$1.14 10-Q · filed 2014-11-10 | -$1.48 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$4.62 10-Q · filed 2013-11-13 | |||||||||||
| 2013-06-30 | -$0.36 10-Q · filed 2014-08-07 | -$0.74 10-Q · filed 2014-08-07 | -$1.07 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$1.46 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$4.35 10-Q · filed 2013-08-13 | |||||||||||
| 2013-03-31 | -$0.39 10-Q · filed 2014-05-08 | -$0.71 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$1.11 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$1.78 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$4.33 10-Q · filed 2013-05-15 | |||||||||||
| 2012-12-31 | -$0.33 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$0.72 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$1.45 derived: net income ÷ weighted average shares · filed 2015-03-16 | -$2.33 10-K · filed 2015-03-16 | -$4.35 10-K · filed 2013-02-25 | |||||||||||
| 2012-09-30 | -$0.42 10-Q · filed 2013-11-13 | -$1.41 derived: net income ÷ weighted average shares · filed 2013-11-13 | -$2.69 10-Q · filed 2013-11-13 | -$5.47 10-Q · filed 2012-11-13 | ||||||||||||
| 2012-06-30 | -$2.09 10-Q · filed 2013-08-13 | -$4.22 10-Q · filed 2013-08-13 | -$7.84 10-Q · filed 2012-08-14 | |||||||||||||
| 2012-03-31 | -$2.14 10-Q · filed 2013-05-15 | |||||||||||||||
| 2011-12-31 | -$3.00 10-K · filed 2014-02-27 | |||||||||||||||
| 2011-09-30 | -$0.89 10-Q · filed 2012-11-13 | -$1.69 10-Q · filed 2012-11-13 | ||||||||||||||
| 2011-06-30 | -$0.78 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |